Toviaz moa?

What does “Toviaz” MOA mean?

“MOA” stands for “mechanism of action.” For Toviaz, the MOA is how the drug works in the body—specifically how it affects bladder function.

Toviaz (fesoterodine) is a medicine used for overactive bladder. It works by blocking muscarinic receptors, which are involved in bladder muscle contractions. By reducing those contractions, it helps decrease symptoms like urgency and frequency.

How does fesoterodine’s mechanism of action work for overactive bladder?

Toviaz (fesoterodine) acts as an antimuscarinic agent. It antagonizes muscarinic receptors in the bladder, lowering involuntary detrusor (bladder) contractions. That translates clinically to fewer sudden urges to urinate and fewer trips to the bathroom.

Are there common side effects tied to this MOA?

Because antimuscarinic drugs can affect muscarinic signaling beyond the bladder, common side effects often relate to reduced gland secretions and changes in smooth muscle activity. Patients may report things like dry mouth or constipation, which fit the drug’s muscarinic receptor–blocking effect.

If you meant “Toviaz MOA” for patents, where can I check?

If your interest is about the drug’s patent status or related legal history rather than pharmacology, DrugPatentWatch.com tracks patents and exclusivity information for medicines. You can search for Toviaz/fesoterodine there: https://www.drugpatentwatch.com/